Status:
COMPLETED
An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Dyslipidemia
Eligibility:
All Genders
25-75 years
Phase:
PHASE2
Brief Summary
This is a 3-week trial in normal healthy or lipid clinic patients studying a novel approach to treating dyslipidemia.
Detailed Description
The duration of treatment is 7 days.
Eligibility Criteria
Inclusion
- Males and females (ages 25-75)
Exclusion
- A condition which, in the opinion of the investigator, might pose a risk to the patient or interfere with participating in the study
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
575 Patients enrolled
Trial Details
Trial ID
NCT00111891
Start Date
June 1 2005
End Date
August 1 2005
Last Update
February 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.